Acetylcholinesterase-inhibiting activity of pyrrole derivatives from a novel marine gliding bacterium, Rapidithrix thailandica

Marine Drugs

Volumn 6, Issue 4, 2008, Pages 578-586

  Sangnoi, Yutthapong ^a   Sakulkeo, Oraphan ^a   Yuenyongsawad, Supreeya ^a   Kanjana opas, Akkharawit ^a,c   Ingkaninan, Kornkanok ^b,c   Plubrukarn, Anuchit ^a,c   Suwanborirux, Khanit ^c  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b NARESUAN UNIVERSITY   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Acetylcholinesterase inhibitors; Gliding bacteria; Phenylpyrroles; Pyrroloquinolines; Rapidithrix thailandica

Indexed keywords

2,2 DIMETHYL PYRROLO 1,2 DIHYDROQUINOLINE; 3 (2' AMINOPHENYL)PYRROLE; CHOLINESTERASE INHIBITOR; MARINOQUINOLINE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; DRUG ISOLATION; ENZYME INHIBITION; IC 50; MARINE BACTERIUM; RAPIDITHRIX THAILANDICA;

BACTERIA (MICROORGANISMS);

EID: 57149117665     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md6040578     Document Type: Article

References (22)

1. Racchi, M.; Mazzuucchelli, M.; Porrello, E.; Lanni, C.; Govoni, S. Acetylcholinesterase Inhibitors: Novel Activities of Old Molecules. Pharmacol. Res. 2004, 50, 441-451.
2. Lanari, A.; Amenta, F.; Silvestrelli, G.; Tomassoni, D.; Parnetti, L. Neurotransmitter Deficits in Behavioral and Psychological Symptoms of Alzheimer's Disease. Mech. Ageing Dev. 2006, 127, 158-165.
3. Srisukchayakul, P.; Suwannachart, C.; Sangnoi, Y.; Kanjana-opas, A.; Hosoya, S.; Yokota, A.; Arunpairojana, V. Rapidithrix thailandica gen. nov., sp. nov., A Marine Gliding Bacteria Isolated from Andaman Sea, the Southern Coastline of Thailand. Int. J. Syst. Evol. Microbiol. 2007, 54, 2275-2279.
4. Kanjana-opas, A.; Panphon, S.; Fun, H.-K.; Chantrapromma, S. 4-Methyl-3H-pyrrolo[2,3-c]quinoline. Acta Cryst. E. 2006, 62, o2728-o2730.
5. Chang, C. J.; Floss, H. G.; Hook, D. J.; Mabe, J. A.; Manni, P. E.; Martin, L. L.; Schröder, K.; Shieh, T. L. The Biosynthesis of the Antibiotic Pyrrolnitrin by Pseudomonas aureofaciens. J. Antibiot. 1981, 34, 555-566.
6. van Pée, K.-H.; Salcher, O.; Fischer, P.; Bokel, M.; Lingens, F. The Biosynthesis of Brominated Pyrrolnitrin Derivatives by Pseudomonas aureofaciens. J. Antibiot. 1983, 36, 1735-1742.
7. 15N Double-Labelled D- and L-Tryptophan. J. Basic Microbiol. 1992, 32, 209-214.
8. Gerth, K.; Trowitzsch, W.; Wray, V.; Höfle, G.; Irschik, H.; Reichenbach, H. Pyrrolnitrin from Myxococcus fulvus (Myxobacterales). J. Antibiot. 1982, 35, 1101-1103.
9. El-Banna, N.; Winkelmann, G. Pyrrolnitrin from Burkholderia capacia: Antibiotic Activity against Fungi and Novel Activities against Streptomycetes. J. Appl. Microbiol. 1998, 85, 69-78.
10. Pohanka, A.; Broberg, A.; Johansson, M.; Kenne, L.; Lavenfors, J. Pseudotrienic Acids A and B, Two Bioactive Metabolites from Pseudomonas sp. MK381-IODS. J. Nat. Prod. 2005, 68, 1380-1385.
11. Kirner, S.; Hammer, P. E.; Hill, D. S.; Altmann, A.; Fischer, I.; Weislo, L. J.; Lanahan, M.; van Pée. K.-H.; Ligon, J. M. Functions Encoded by Pyrrolnitrin Biosynthesis Genes from Pseudomonas fluorescens. J. Bacteriol. 1998, 180, 1939-1943.
12. Muñoz-Ruiz, P.; Rubio, L.; García-Palomero, E.; Dorrensoro, I.; del Monte-Millán, M.; Valenzuela, R.; Usán, P.; de Austria, C.; Bartolini, M.; Andrisano, V.; Bidon-Chanal, A.; Orozco, M.; Luque, F. J.; Medina, M.; Martínez, A. Design, Synthesis, and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease-Modifying Agents for Alzheimer's Disease. J. Med. Chem. 2005, 48, 7223-7233.
13. da Silva, C. H. T. P.; Campo, V. L.; Carvalho, I.; Taft, C. A. Molecular Modeling, Docking and ADMET Studies Applied to the Design of a Novel Hybrid for Treatment of Alzheimer's Disease. J. Mol. Graph. Model. 2006, 25, 169-175.
14. Hosoya, S.; Arunpairojana, V.; Suwannachart, C.; Kanjana-opas, A.; Yokota, A. Aureispira marina gen. nov., sp., nov., a Gliding Arachidonic Acid-Containing Bacterium Isolated from the Southern Coastline of Thailand. Int. J. Syst. Evol. Microbiol. 2006, 56, 2931-2935.
15. Zhang, P. L.; Wang, Y. H.; Fang, M. X.; Stackebrandt, E.; Ding, B. Y. Improved Methods of Isolation and Purification of Myxobacteria and Development of Fruiting Body Formation of Two Strains. J. Microbiol. Meth. 2003, 54, 21-27.
16. Reichenbach, H. In The Prokaryotes; Balows,A.; Truper, H. G.; Dworkin, M.; Harder, W.; Schleifer, K. H., Eds.; Springer-Verlog: New York, 1992; Vol. 4, The Order Cytophagales, pp 3631-3675.
17. Hall, T. A. Bioedit: A User-Friendly Biological Sequence Alignment Editor and Analysis Program for Window 95/98/NT. Nucleic Acids Symp. Ser. 1999, 41, 765-768.
18. Suzuki, Y.; Ojia, M.; Sakagami, Y.; Fudou, R.; Yamanaka, S. Cystothiazoles C-F, New Bithiazole-Type Antibiotics from the Myxobacterium Cystobacter fuscus. Tetrahedron. 1998, 54, 11399-11404.
19. Vobis, G. In The Prokaryotes; Balows,A.; Truper, H. G.; Dworkin, M.; Harder, W.; Schleifer, K. H., Eds.; Springer-Verlog: New York, 1992; Vol. 2, The Genus Actinoplanes and Related Genera, pp 1031-1060.
20. Ingkaninan, K.; Changwijit, K.; Suwanborirux, K. Vobasinyl-Iboga Bisindole Alkaloids, Potent Acetylcholinesterase Inhibitors from Tabernaemontana divaricata Root. J. Pharm. Pharmacol. 2006, 58, 847-852.
21. Ellman, G. L.; Courtney, K. D.; Andres, V., Jr.; Featherstone. R. M. A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity. Biochem. Pharmacol. 1961, 7, 88-95.
22. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahan, J.; Vistica, D.; Warren, J. T., Bokesch, H.; Kenney, S. New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.